Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A stock index tracks a group of stocks to represent market performance, guiding benchmarks and passive investment strategies.
28,657 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
June 2026 looked like a milestone month for Oklo, but the stock went the other way. This deep dive explains why the s...
Rocket Lab’s stock has faced renewed pressure as the market weighs contracting demand signals and execution risks. Th...
A leading wealth manager launches a new regional bank holding with $4.5 million in seed capital. Explore what this me...
When high-profile investors tilt toward value, curious readers take note. This piece breaks down why billionaire Bill...
Two compelling reasons berkshire hathaway stock could shine in any market. This piece breaks down the moat, cash flow...
Bold claims about doubling your money tempt investors. This guide explains realistic paths to potential outsized gain...
Explore how centrus energy (leu) 2026 shapes the investing picture. This guide breaks down Q1 2026 earnings signals, ...
Alta Fox quietly increases its XPEL exposure, lifting the stake to about 15.5% after a roughly $58 million purchase. ...
A big stock move and a buyout rumor are reshaping how traders view NCR Atleos. A large block sale drew attention, jus...
The Gates Foundation is recalibrating after Bill Gates pulled from a New Delhi AI summit and newly released DoJ email...
As retirees navigate a labyrinth of spousal-benefit rules, new online tools and policy chatter could reshape how coup...